![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 34, 32005-32013, August 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Surgery, Stanford University School of Medicine, Stanford University, Stanford, California 94305-5148
The ability of immature animals to orchestrate successful calvarial
ossification has been well described. This capacity is markedly attenuated in
mature animals and humans greater than 2 years of age. Few studies have
investigated biological differences between juvenile and adult osteoblasts
that mediate successful osteogenesis. To identify possible mechanisms for this
clinical observation, we investigated cellular and molecular differences
between primary osteoblasts derived from juvenile (2-day-old) and adult
(60-day-old) rat calvaria. Data demonstrated that juvenile osteoblasts contain
a subpopulation of less differentiated cells as observed by spindle-like
morphology and decreased osteocalcin production. Juvenile, compared with
adult, osteoblasts showed increased proliferation and adhesion. Furthermore,
following rhFGF-2 stimulation juvenile osteoblasts increased expression of
collagen I
1 (5-fold), osteopontin (13-fold), and osteocalcin (16-fold),
compared with relatively unchanged adult osteoblasts. Additionally, juvenile
osteoblasts organized and produced more matrix proteins and formed 41-fold
more bone nodules. Alternatively, adult osteoblasts produced more FGF-2 and
preferentially translated the high molecular weight (22 kDa) form. Although
adult osteoblasts transcribed more FGF-R1 and juvenile osteoblasts transcribed
more FGF-R2 at baseline levels, juvenile osteoblasts translated more FGF-R1
and -R2 and showed increased phosphorylation. Collectively, these findings
begin to explain why juvenile, but not adult, osteoblasts successfully heal
calvarial defects.
Received for publication, May 6, 2003 , and in revised form, May 30, 2003.
* This work was supported by Grant R01DE-14526 from the National Institutes of Health (to M. T. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Surgery, Stanford
University School of Medicine, 257 Campus Dr., Stanford, CA 94305-5148. Tel.:
650-736-1707; Fax: 650-736-1705; E-mail:
Longaker{at}Stanford.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. D. Kwan, B. J. Slater, D. C. Wan, and M. T. Longaker Cell-based therapies for skeletal regenerative medicine Hum. Mol. Genet., April 15, 2008; 17(R1): R93 - R98. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, N. Quarto, and M. T. Longaker Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1834 - C1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Dupree, S. R. Pollack, E. M. Levine, and C. T. Laurencin Fibroblast Growth Factor 2 Induced Proliferation in Osteoblasts and Bone Marrow Stromal Cells: A Whole Cell Model Biophys. J., October 15, 2006; 91(8): 3097 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Malecki, J. Wesche, C. S. Skjerpen, A. Wiedlocha, and S. Olsnes Translocation of FGF-1 and FGF-2 across Vesicular Membranes Occurs during G1-Phase by a Common Mechanism Mol. Biol. Cell, February 1, 2004; 15(2): 801 - 814. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |